No NFO data available for this page.
3 Year return
0Investment Details
Calculate Returns
Based on past performance of this fund
Risk Involved
Tax Implications
Fund Holdings
Top Holdings | % of Asset |
---|---|
Divis Laboratories Ltd | 7.83% |
Lupin Ltd | 6.10% |
Aurobindo Pharma Ltd | 4.98% |
Alkem Laboratories Ltd | 3.73% |
Zydus Lifesciences Ltd | 3.71% |
Others | 73.65% |
Other Holdings | % of Asset |
---|---|
Torrent Pharmaceuticals Ltd | 3.71% |
Sun Pharmaceutical Industries Ltd | 24.91% |
Ipca Laboratories Ltd | 2.77% |
Laurus Labs Ltd | 2.72% |
Mankind Pharma Ltd | 2.62% |
Glenmark Pharmaceuticals Ltd | 2.43% |
Abbott India Ltd | 2.16% |
J B Chemicals & Pharmaceuticals Ltd | 2.09% |
Biocon Ltd | 2.04% |
Dr Reddys Laboratories Ltd | 11.60% |
Cipla Ltd | 11.28% |
Gland Pharma Ltd | 1.82% |
Natco Pharma Ltd | 1.42% |
Sanofi India Ltd | 1.15% |
Granules India Ltd | 0.88% |
NA
Fund House Details
Peer Comparison
Comparison with other similar funds
Funds
|
3 Y Returns
|
ARQ Rating
|
---|---|---|
DSP Nifty Next 50 Index Fund Direct Plan IDCW Payout |
23.03% |
0 |
LIC MF Nifty Next 50 Index Fund Direct Plan IDCW Payout |
22.95% |
0 |
ICICI Prudential Nifty Next 50 Index Fund Direct Plan IDCW Payout |
22.89% |
0 |
Schemes by ICICI Prudential Mutual Fund
List of mutual fund schemes by AMC
Key Features of The Fund
5-year return | NA |
Expense Ratio | NA |
Fund Manager | NA |
Fund Size | NA |
Risk Profile | NA |
AMC Contact Details
Name | NA |
Launch Date | NA |
Addresss | NA |
Contact | NA |
NA | |
Website | NA |
Disclaimer: Mutual funds are subject to market risk. Read all scheme-related documents carefully to make informed-decision.